Using the magnetoencephalogram to noninvasively measure magnetite in the living human brain

During the past several decades there has been much interest in the existence of magnetite particles in the human brain and their accumulation with age. These particles also appear to play an important role in neurodegenerative diseases of the brain. However, up to now the amount and distribution of these particles has been measured only in post‐mortem brain tissue. Although in‐vivo MRI measurements do show iron compounds generally, MRI cannot separate them according to their magnetic phases, which are associated with their chemical interactions. In contrast, we here offer a new noninvasive, in‐vivo method which is selectively sensitive only to particles which can be strongly magnetized. We magnetize these particles with a strong magnetic field through the head, and then measure the resulting magnetic fields, using the dcMagnetoencephalogram (dcMEG). From these data, the mass and locations of the particles can be estimated, using a distributed inverse solution. To test the method, we measured 11 healthy male subjects (ages 19–89 year). Accumulation of magnetite, in the hippocampal formation or nearby structures, was observed in the older men. These in‐vivo findings agree with reports of post‐mortem measurements of their locations, and of their accumulation with age. Thus, our findings allow in‐vivo measurement of magnetite in the human brain, and possibly open the door for new studies of neurodegenerative diseases of the brain.

[1]  Anna Papst,et al.  Introduction To Magnetism And Magnetic Materials , 2016 .

[2]  Gabriel Curio,et al.  Combined MEG and EEG methodology for non-invasive recording of infraslow activity in the human cortex , 2007, Clinical Neurophysiology.

[3]  J. Kirschvink,et al.  Magnetite biomineralization in the human brain. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Josep Samitier,et al.  Magnetite-Amyloid-β deteriorates activity and functional organization in an in vitro model for Alzheimer’s disease , 2015, Scientific Reports.

[5]  J. Collingwood,et al.  Iron Oxides in the Human Brain , 2016 .

[6]  E. Halgren,et al.  Dynamic Statistical Parametric Mapping Combining fMRI and MEG for High-Resolution Imaging of Cortical Activity , 2000, Neuron.

[7]  Jon Dobson,et al.  Magnetic Iron Compounds in Neurological Disorders , 2004, Annals of the New York Academy of Sciences.

[8]  G. Perry,et al.  Three-dimensional tomographic imaging and characterization of iron compounds within Alzheimer's plaque core material. , 2008, Journal of Alzheimer's disease : JAD.

[9]  Xiongwei Zhu,et al.  High-resolution analytical imaging and electron holography of magnetite particles in amyloid cores of Alzheimer’s disease , 2016, Scientific Reports.

[10]  J. Clegg Rock magnetism , 1956, Nature.

[11]  N. Raz,et al.  Appraising the Role of Iron in Brain Aging and Cognition: Promises and Limitations of MRI Methods , 2015, Neuropsychology Review.

[12]  P. Riederer,et al.  The link between iron, metabolic syndrome, and Alzheimer’s disease , 2011, Journal of Neural Transmission.

[13]  G. Bartzokis,et al.  In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging. , 2000, Archives of general psychiatry.

[14]  R. McFee,et al.  DETECTION OF THE MAGNETIC FIELD OF THE HEART. , 1963, American heart journal.

[15]  Min Lou,et al.  Evaluation of Brain Iron Content Based on Magnetic Resonance Imaging (MRI): Comparison among Phase Value, R2* and Magnitude Signal Intensity , 2012, PloS one.

[16]  Q. Pankhurst,et al.  Superconducting quantum interference device measurements of dilute magnetic materials in biological samples , 2005 .

[17]  Q. Pankhurst,et al.  Increased levels of magnetic iron compounds in Alzheimer's disease. , 2008, Journal of Alzheimer's disease : JAD.

[18]  J. Dobson,et al.  Nanoscale biogenic iron oxides and neurodegenerative disease , 2001, FEBS letters.

[19]  S. Ropele,et al.  Quantitative MR imaging of brain iron: a postmortem validation study. , 2010, Radiology.

[20]  Iku Nemoto,et al.  Ferrimagnetic Particles in the Lung Part II: The Relaxation; Process , 1984, IEEE Transactions on Biomedical Engineering.

[21]  J. Dobson,et al.  TEM investigations of biogenic magnetite extracted from the human hippocampus. , 1999, Biochimica et biophysica acta.

[22]  D. Jiles Introduction to Magnetism and Magnetic Materials , 2015 .

[23]  D Cohen DC magnetic fields from the human body generally: a historical overview. , 2004, Neurology & clinical neurophysiology : NCN.

[24]  D. Faivre Iron Oxides: From Nature to Applications , 2016 .

[25]  D. Kido,et al.  Mineralization of the Deep Gray Matter with Age: A Retrospective Review with Susceptibility-Weighted MR Imaging , 2008, American Journal of Neuroradiology.

[26]  J. Scaiano,et al.  Dramatic Effect of Magnetite Particles on the Dynamics of Photogenerated Free Radicals , 1997 .

[27]  D. Cohen Magnetoencephalography: Detection of the Brain's Electrical Activity with a Superconducting Magnetometer , 1972, Science.

[28]  J. Dobson Investigation of age-related variations in biogenic magnetite levels in the human hippocampus , 2002, Experimental Brain Research.

[29]  Seppo P. Ahlfors,et al.  New Six-Layer Magnetically-Shielded Room for MEG , 2002 .

[30]  B N Cuffin,et al.  Magnetic fields produced by steady currents in the body. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[31]  L. Trahms,et al.  DC-magnetoencephalography and time-resolved near-infrared spectroscopy combined to study neuronal and vascular brain responses , 2007, Physiological measurement.

[32]  Richard Bowtell,et al.  Safety Implications of High-Field MRI: Actuation of Endogenous Magnetic Iron Oxides in the Human Body , 2009, PloS one.

[33]  George Perry,et al.  Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. , 2010, Journal of Alzheimer's disease : JAD.

[34]  Iku Nemoto,et al.  Ferrimagnetic Particles in the Lung Part 1: The Magnetizing Process , 1984, IEEE Transactions on Biomedical Engineering.

[35]  C. Quintana,et al.  Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level. , 2006, Journal of structural biology.

[36]  C. Jenkins,et al.  Evidence of redox-active iron formation following aggregation of ferrihydrite and the Alzheimer's disease peptide β-amyloid. , 2014, Inorganic chemistry.

[37]  Mingui Sun,et al.  Detection of magnetic nanoparticles with magnetoencephalography , 2008 .

[38]  M. Wessling-Resnick,et al.  Olfactory uptake of manganese requires DMT1 and is enhanced by anemia , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[39]  J. Dobson,et al.  Mapping and characterization of iron compounds in Alzheimer's tissue , 2006 .

[40]  H Hosaka,et al.  Part II: magnetic field produced by a current dipole. , 1976, Journal of electrocardiology.

[41]  D. Mann,et al.  Magnetite pollution nanoparticles in the human brain , 2016, Proceedings of the National Academy of Sciences.

[42]  C. Batich,et al.  In situ characterization and mapping of iron compounds in Alzheimer's disease tissue. , 2005, Journal of Alzheimer's disease : JAD.

[43]  D. Cohen,et al.  Magnetic Measurement of S‐T and T‐Q Segment Shifts in Humans: Part I Early Repolarization and Left Bundle Branch Block , 1983, Circulation research.

[44]  Norman Tepley,et al.  Slow Brain Activity (ISA/DC) Detected by MEG , 2012, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[45]  Q. Pankhurst,et al.  Looking for biogenic magnetite in brain ferritin using NMR relaxometry , 2005, NMR in biomedicine.

[46]  Distribution of magnetic remanence carriers in the human brain , 2018, Scientific Reports.

[47]  J. Kirschvink,et al.  Magnetite in human tissues: a mechanism for the biological effects of weak ELF magnetic fields. , 1992, Bioelectromagnetics.

[48]  G. Perry,et al.  Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Q. Pankhurst,et al.  Preliminary evaluation of nanoscale biogenic magnetite in Alzheimer's disease brain tissue , 2003, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[50]  B. Hallgren,et al.  THE EFFECT OF AGE ON THE NON‐HAEMIN IRON IN THE HUMAN BRAIN , 1958, Journal of neurochemistry.

[51]  Xiongwei Zhu,et al.  Iron: The Redox-active Center of Oxidative Stress in Alzheimer Disease , 2007, Neurochemical Research.